Lumpy export order pattern
Oncology exports are tender-driven and may not follow a smooth quarterly trajectory, making near-term revenue lumpy.
SAKAR / Q4-FY26 / risks
Keep the risk register visible.
Sakar Healthcare · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
medium
Regulatory approval delays for Accord products
Only 2 of 9 Accord tech transfers are commercialized; remaining 7 await EMA approval, which could slip.
Geopolitical and freight cost risks
Middle East conflict could indirectly impact API costs and logistics, though management claims contractual pass-through.